MENU
GENW
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

GENW stock forecast, quote, news & analysis

The investment seeks current income and long-term capital appreciation... Show more

GENW
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for GENW with price predictions
Jul 02, 2026

GENW in upward trend: price expected to rise as it breaks its lower Bollinger Band on June 10, 2026

GENW may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 5 cases where GENW's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 14 cases where GENW's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GENW advanced for three days, in of 55 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 122 cases where GENW Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 26, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on GENW as a result. In of 14 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for GENW turned negative on June 23, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 15 similar instances when the indicator turned negative. In of the 15 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GENW declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are AstraZeneca PLC (NYSE:AZN), BP plc (NYSE:BP), Barclays PLC (NYSE:BCS), Ericsson (NASDAQ:ERIC).

Industry description

The investment seeks current income and long-term capital appreciation. Under normal market conditions, the fund will invest at least 80% of its assets plus borrowings for investment purposes in foreign equity securities that have records of paying dividends. In addition, the fund will invest in a diversified portfolio of 25 to 50 securities typically spread across many economic sectors.

Market Cap

The average market capitalization across the Genter Capital International Div ETF ETF is 117.98B. The market cap for tickers in the group ranges from 26.59B to 301.62B. NVS holds the highest valuation in this group at 301.62B. The lowest valued company is NMR at 26.59B.

High and low price notable news

The average weekly price growth across all stocks in the Genter Capital International Div ETF ETF was 1%. For the same ETF, the average monthly price growth was 1%, and the average quarterly price growth was 13%. HMC experienced the highest price growth at 7%, while ENB experienced the biggest fall at -4%.

Volume

The average weekly volume growth across all stocks in the Genter Capital International Div ETF ETF was 18%. For the same stocks of the ETF, the average monthly volume growth was 47% and the average quarterly volume growth was 33%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 26
P/E Growth Rating: 48
Price Growth Rating: 48
SMR Rating: 54
Profit Risk Rating: 36
Seasonality Score: 7 (-100 ... +100)
View a ticker or compare two or three
GENW
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category ForeignLargeValue

Profile
Details
GENW in upward trend: price expected to rise as it breaks its lower Bollinger Band on June 10, 2026